Shanshan Li | Molecular Biology | Excellence in Research Award

Published on by Molecular Biologist

Dr. Shanshan Li | Molecular Biology | Excellence in Research Award

Assistant Researcher | Zhejiang University | China

Dr. Shanshan Li is a dedicated researcher specializing in the chemistry, processing, and bioactivity of bee-derived products, with a strong emphasis on propolis, royal jelly, and protein–polyphenol systems. Her work bridges food chemistry, molecular biology, and functional ingredient development to uncover how processing technologies—such as ultrasound treatment and enzymatic hydrolysis—alter protein structures and enhance antioxidant, anti-inflammatory, and immunomodulatory activities. She has significantly advanced the understanding of protein–polyphenol interactions and their role in improving the functional properties of natural compounds. Dr. Li employs advanced analytical approaches, including proteomics, transcriptomics, and bioinformatics, to investigate molecular mechanisms and cellular pathways influenced by bee product components. Her research also includes comparative studies of milk fat globule membrane proteins across animal species, contributing to broader innovations in food science and bioactive ingredient development. With 998 citations across 943 documents, 50 publications, and an h-index of 21, Dr. Li has established a strong scientific presence. Her contributions support the development of health-promoting ingredients and the translation of natural bioactives into functional foods.

Profiles: Scopus

Featured Publications

Ultrasound-induced modifications in structure, antioxidant activity and functionality of whey protein isolate–propolis polyphenol conjugates. Food Chemistry.

Integrated transcriptomics and network pharmacology reveal the mechanism of poplar-type propolis on the mouse mastitis model. Nutrients.

Structural and antioxidative properties of royal jelly protein by partial enzymatic hydrolysis. Food Science and Human Wellness.

Royal jelly proteins and their derived peptides: Preparation, properties, and biological activities. Journal of Agricultural and Food Chemistry.

Milk fat globule membrane proteins among buffalo breeds via TMT proteomics. Food Research International.

 

Georges Nemer | Molecular Biology | Editorial Board Member

Published on by Molecular Biologist

Prof. Georges Nemer | Molecular Biology | Editorial Board Member 

Professor | Hamad Bin Khalifa University | Qatar

Dr. Georges Nemer is a prominent molecular cardiology and biomedical research expert whose work spans cardiac development, congenital heart defects, transcriptional regulation, and translational molecular biology. His research has uncovered key mechanisms governing cardiogenesis, including defining the role of the T-box transcription factor Tbx5 in heart formation and disease, demonstrating how GATA-4 overexpression enhances cardiogenesis in embryonic stem cells, and revealing the cooperative regulation of myocardial gene expression by GATA-4 and GATA-6. Dr. Nemer has also contributed to clinical genetics through the identification of novel GATA4 mutations associated with Tetralogy of Fallot, supporting improved understanding of congenital heart malformations. Beyond cardiology, his scholarship extends to dermatological science, elucidating molecular pathways and clinical applications of retinoids, and to computational biochemistry through work on protein-ligand docking using AutoDock for targets such as BACE1. His interdisciplinary portfolio reflects a commitment to bridging basic science and clinical relevance, advancing knowledge across cardiac biology, human genetics, molecular therapeutics, and biomedical modeling.

Profile: Google Scholar

Featured Publications

Bruneau, B. G., Nemer, G., Schmitt, J. P., Charron, F., Robitaille, L., Caron, S., …
(2001). A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell, 106(6), 709–721.

Grépin, C., Nemer, G., & Nemer, M. (1997). Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development, 124(12), 2387–2395.

Charron, F., Paradis, P., Bronchain, O., Nemer, G., & Nemer, M. (1999). Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Molecular and Cellular Biology, 19(6), 4355–4365.

Khalil, S., Bardawil, T., Stephan, C., Darwiche, N., Abbas, O., Kibbi, A. G., …
(2017). Retinoids: A journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects. Journal of Dermatological Treatment, 28(8), 684–696.

Nemer, G., Fadlalah, F., Usta, J., Nemer, M., Dbaibo, G., Obeid, M., & Bitar, F. (2006). A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Human Mutation, 27(3), 293–294.

El-Hachem, N., Haibe-Kains, B., Khalil, A., Kobeissy, F. H., & Nemer, G. (Year unavailable). AutoDock and AutoDockTools for protein-ligand docking: Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a case study. Neuroproteomics: Methods and Protocols, 391–403.

Maria Camprubi Robles | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Maria Camprubi Robles | Molecular Biology | Best Researcher Award 

Research Scientist | Abbott Laboratories | Spain

Dr. Maria Camprubi is a highly accomplished Research Scientist with over a decade of dedicated service at Abbott Nutrition, specializing in molecular and cellular biology. With strong expertise in nutritional science, she has significantly contributed to the development of innovative products that address sarcopenia, chronic disease, and malnutrition across Europe, the Middle East, and Africa. She holds a Ph.D. in Molecular and Cellular Biology, where she built a strong foundation in cellular processes and metabolic regulation. Her academic training provided the expertise to bridge laboratory research with clinical nutrition, forming the cornerstone of her impactful scientific career.  Dr. Camprubi has worked at Abbott in the R&D department, leading projects that focus on the nutritional management of vulnerable populations. Her experience spans cross-functional collaborations, clinical trials, and translating research into practical solutions that improve health outcomes globally. Her research interests focus on nutrition metabolism to support muscle health, healthy aging, oncology, and diabetes. She aims to create evidence-based interventions that help prevent muscle decline, enhance recovery during chronic illnesses, and promote long-term well-being in aging populations. Dr. Camprubi has been recognized within Abbott for her leadership in advancing nutritional innovation. Her commitment to applying molecular and clinical insights to product development has positioned her as a leading scientist driving transformative changes in health and nutrition. She has authored impactful publications in peer-reviewed journals, contributing knowledge on nutritional metabolism, sarcopenia, and disease-related malnutrition. Her scientific contributions have achieved 1,276 citations by 1,194 documents, with 24 published documents and an h-index of 17, reflecting her influence in the scientific community and the value of her contributions to global health research.

Profile: Scopus

Featured Publications

A prospective, observational study of the effect of a high-calorie, high-protein oral nutritional supplement with HMB in an old and malnourished or at-risk-of-malnutrition population with hip fractures: A FracNut study. Nutrients, 16(8)

The vicious cycle of type 2 diabetes mellitus and skeletal muscle atrophy: Clinical, biochemical, and nutritional bases. Nutrients, 16(1), 172